Synergistic Protection System for Human Papilloma Virus and Sexually Transmitted Infections
Legal Citation
Summary of the Inventive Concept
A novel system integrating copper-based uterine cervical devices with AI, IoT, blockchain, and nanomaterial technologies to provide enhanced protection against human papilloma virus and sexually transmitted infections, while optimizing treatment protocols and user health metrics.
Background and Problem Solved
The original patent disclosed a method for reducing the incidence and prevalence of human papilloma virus (HPV) using a copper-based uterine cervical device. However, the method had limitations in terms of tracking user health metrics, predicting disease risk, and providing personalized treatment recommendations. The new inventive concept addresses these limitations by synergistically combining the original method with advanced technologies, enabling a more comprehensive and effective approach to preventing HPV and sexually transmitted infections.
Detailed Description of the Inventive Concept
The synergistic protection system comprises a wearable device with a copper-based uterine cervical module, a blockchain-based data storage module, and an AI-powered analytics module. The copper-based module reduces the incidence and prevalence of HPV, while the blockchain module securely stores user health metrics and treatment protocols. The AI-powered analytics module predicts disease risk and provides personalized treatment recommendations based on user-specific data. Additionally, IoT sensors can be integrated to monitor and adjust the device's performance in real-time, and nanomaterial-based delivery systems can be used for targeted release of therapeutic agents. The system enables real-time monitoring, personalized treatment, and optimized health outcomes.
Novelty and Inventive Step
The new claims introduce the innovative combination of copper-based uterine cervical devices with AI, IoT, blockchain, and nanomaterial technologies, which provides a synergistic effect in preventing HPV and sexually transmitted infections. This integration of distinct technologies is new and non-obvious compared to the original patent, and enables a more comprehensive and effective approach to preventing these diseases.
Alternative Embodiments and Variations
Alternative embodiments of the synergistic protection system could include different wearable device designs, varying AI-powered analytics algorithms, or integration with other health monitoring systems. Variations could also include using different materials or geometries for the uterine cervical module, or incorporating additional sensors or actuators to enhance the system's functionality.
Potential Commercial Applications and Market
The synergistic protection system has significant commercial potential in the healthcare and medical device industries, particularly in the areas of women's health and infectious disease prevention. The system's ability to provide enhanced protection against HPV and sexually transmitted infections, while optimizing treatment protocols and user health metrics, makes it an attractive solution for healthcare providers, insurers, and patients.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/0039 |
| A | A61 | A61F6/144 |
| A | A61 | A61K33/34 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technologies for reproductive health, specifically focused on intrauterine devices (IUDs), microbiome modification, and infection prevention technologies with expertise in materials science, biotechnology, and digital health monitoring systems
Person of Ordinary Skill (PHOSITA) Profile
A skilled practitioner with advanced degrees in biomedical engineering, medical device design, or clinical biotechnology, possessing comprehensive knowledge of reproductive health technologies, digital health integration, and materials-based medical interventions
Obviousness Rationale
A person having ordinary skill would recognize that integrating digital monitoring technologies with existing copper-based uterine cervical devices represents a predictable technological evolution. The source patent's foundational method for HPV prevention provides a clear technical framework that naturally invites enhancement through contemporary digital health technologies. The combination of copper-based medical devices with AI, blockchain, and IoT represents an incremental and foreseeable technological progression within the medical device domain.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,675 |
|---|---|
| Title | Method for reducing the incidence and prevalence of human papilloma virus (HPV) and for providing protection against sexually transmitted infections |